GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 54 filers reported holding GENERATION BIO CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,345,591 | +7.8% | 1,410,446 | +56.5% | 0.00% | 0.0% |
| Q2 2023 | $4,957,244 | +148.6% | 901,317 | +94.3% | 0.00% | – |
| Q1 2023 | $1,994,000 | +109883.5% | 463,854 | +0.6% | 0.00% | – |
| Q4 2022 | $1,813 | -99.9% | 461,140 | +0.7% | 0.00% | – |
| Q3 2022 | $2,433,000 | -42.4% | 458,075 | -28.9% | 0.00% | -100.0% |
| Q2 2022 | $4,226,000 | -12.8% | 644,256 | -2.4% | 0.00% | 0.0% |
| Q1 2022 | $4,847,000 | +21.8% | 660,275 | +17.5% | 0.00% | – |
| Q4 2021 | $3,979,000 | -91.2% | 562,005 | -68.9% | 0.00% | -100.0% |
| Q3 2021 | $45,376,000 | +15.1% | 1,809,978 | +23.5% | 0.01% | +20.0% |
| Q2 2021 | $39,437,000 | -8.4% | 1,466,092 | -3.1% | 0.01% | -16.7% |
| Q1 2021 | $43,053,000 | +94.9% | 1,512,765 | +94.2% | 0.01% | +100.0% |
| Q4 2020 | $22,086,000 | +35.6% | 779,070 | +47.9% | 0.00% | 0.0% |
| Q3 2020 | $16,284,000 | +66.1% | 526,634 | +12.8% | 0.00% | +50.0% |
| Q2 2020 | $9,806,000 | – | 466,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |